.Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01C_SpecificAntirheumaticAgents.M01CB05_Aurotioprol.Aurotioprol .Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01C_SpecificAntirheumaticAgents.M01CB05_Aurotioprol.Aurotioprol| name: | Aurotioprol |
| ATC code: | M01CB05 | route: | intramuscular |
| n-compartments | 2 |
Aurotioprol is an organogold compound that was developed for the treatment of rheumatoid arthritis and other related inflammatory conditions. It is classified as a disease-modifying antirheumatic drug (DMARD) and shares pharmacological properties with other gold-based agents. However, aurotioprol is not currently approved for use, and its use has largely been superseded by safer and more effective medications.
No published pharmacokinetic data are available for aurotioprol in humans or animals. The following pharmacokinetic parameters are provided based on estimated values from similar gold-based DMARDs used in the treatment of rheumatoid arthritis.